![](/img/cover-not-exists.png)
Reply to the Letter to the Editor by Hughes in response to the article entitled “Multicentre randomised Phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced NSCLC”, published in vol. 41 Issue 1 of the European Journal of Cancer
Andrea Martoni, Lorenzo MantovaniVolume:
41
Year:
2005
Language:
english
Pages:
1658
DOI:
10.1016/j.ejca.2005.02.032
File:
PDF, 66 KB
english, 2005